| Food Products Industry | Consumer Staples Sector | Mr. Samuel Watson CEO | ASX Exchange | Q77474122 CUSIP |
| Australia Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Bioxyne Limited is a dynamic life sciences and consumer health products company with a global reach, including the United Kingdom, Japan, Europe, and Australia. Established in 1998 and headquartered in Sydney, Australia, the company specializes in the manufacture and distribution of a broad range of consumer health products. These include patented probiotics, health supplements, therapeutic goods, and alternative medicines. Bioxyne Limited is deeply committed to enhancing wellness through its diverse product portfolio, which leverages the power of plant-based components and cutting-edge scientific research. The company's operations also extend to the provision of product research and development services and the innovative use of telemedicine through its BLS Clinics platform.
Bioxyne Limited offers an extensive array of products and services designed to promote health and well-being among consumers worldwide: